REQUEST A DEMO
Total
USD $0.00
Search more companies

Amgen Biopharmaceuticals Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Amgen Biopharmaceuticals Malaysia Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Amgen Biopharmaceuticals Malaysia Sdn. Bhd. is a company based in Malaysia, with its head office in Subang Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on April 03, 2019. In 2022, the company reported a net sales revenue increase of 34.58%. Over the same period, its total assets grew by 87.66%. In 2022, Amgen Biopharmaceuticals Malaysia Sdn. Bhd.’s net profit margin increased by 0.9%.

Headquarters
Suite 9.01, Level 9, Menara Summit, Persiaran Kewajipan, Usj 1, Uep
Subang Jaya; Selangor; Postal Code: 47600

Contact Details: Purchase the Amgen Biopharmaceuticals Malaysia Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Amgen Biopharmaceuticals Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Amgen Biopharmaceuticals Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
April 03, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Amgen Biopharmaceuticals Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
34.58%
Total operating revenue
34.58%
Operating profit (EBIT)
41.6%
Net Profit (Loss) for the Period
54.59%
Total assets
87.66%
Total equity
32.03%
Operating Profit Margin (ROS)
0.46%
Net Profit Margin
0.9%
Return on Equity (ROE)
3.4%
Quick Ratio
-6.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?